HORAN Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$547K Sell
9,491
-8,965
-49% -$515K 0.07% 139
2026
Q1
$1.03M Buy
18,456
+9,229
+100% +$538K 0.1% 95
2025
Q4
$498K Sell
9,227
-844
-8% -$40.6K 0.08% 121
2025
Q3
$454K Buy
+10,071
New +$470K 0.07% 137

Other funds holding BMY

HORAN Wealth's BMY Position: Q2 2026 in Review

HORAN Wealth reduced its Bristol-Myers Squibb (BMY) stake by 49% in Q2 2026, selling an estimated $515K and leaving 9,491 shares worth $547K. The position accounts for 0.07% of the portfolio, ranked #139.

HORAN Wealth first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.03M in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • HORAN Wealth held 9,491 shares of Bristol-Myers Squibb worth $547K as of Q2 2026.
  • HORAN Wealth sold 8,965 Bristol-Myers Squibb shares in Q2 2026, an estimated $515K.
  • Bristol-Myers Squibb made up 0.07% of HORAN Wealth's portfolio in Q2 2026, its #139 holding.
  • HORAN Wealth first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
  • HORAN Wealth's Bristol-Myers Squibb position peaked at $1.03M in Q1 2026.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on HORAN Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.